Dr Veronica Di Carlo

Research Fellow

United Kingdom

Email
Veronica

I graduated in Economics from the University of Salerno (Italy) in 2012 and then completed a Masters in Statistics at the University of Bologna (Italy) in 2014. In 2024, I completed a PhD at LSHTM aiming at explaining global variation in population-based survival from malignant melanoma.

I joined the Cancer Survival Group in 2015 and I’m working in the CONCORD programme and VENUSCANCER project.

Affiliations

Department of Non-communicable Disease Epidemiology

Faculty of Epidemiology and Population Health

Teaching

Statistical Methods in Epidemiology (2402)

Statistics for EPH (2402),

Cancer survival: principles, methods and analysis (short course)

Research

My main research interests are in international comparisons of population-based cancer survival, which are designed to measure the comparative effectiveness of health systems in cancer control, and thus to influence cancer control policy.

I'm particularly interested in explaining the wide global variation in population-based survival from malignant melanoma in countries partecipating in the CONCORD programme.

I am part of the CONCORD and VENUSCANCER Central Analytic Team. VENUSCANCER is a high-resolution study aiming at explaining the reasons for world-wide disparities in survival for women's cancer by looking at detailed information on tumour biology, stage, staging procedures, treatments and socio-economic variables.

I’m also involved in the modelling of life tables for countries participating in the CONCORD study by applying a new multivariable, flexible model developed in the Cancer Survival Group to estimate complete, smoothed life tables for sub-national populations.

Selected Publications

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).

DI CARLO, V; Stiller, CA; Eisemann, N; Bordoni, A; MATZ, M; Curado, MP; Daubisse-Marliac, L; Valkov, M; Bulliard, J-L; Morrison, D; Johnson, C; GIRARDI, F; Marcos-Gragera, R; Šekerija, M; Larønningen, S; Sirri, E; COLEMAN, MP; ALLEMANI, C; CONCORD Working Group,;

2022

The British journal of dermatology

Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3).

DI CARLO, V; Estève, J; Johnson, C; GIRARDI, F; Weir, HK; Wilson, RJ; MINICOZZI, P; Cress, RD; Lynch, CF; Pawlish, KS; Rees, JR; COLEMAN, MP; ALLEMANI, C; US CONCORD Working Group,;

2020

JNCI cancer spectrum

Sustainable care for children with cancer: a Lancet Oncology Commission.

Atun, R; Bhakta, N; Denburg, A; Frazier, AL; Friedrich, P; Gupta, S; Lam, CG; Ward, ZJ; Yeh, JM; ALLEMANI, C; COLEMAN, MP; DI CARLO, V; Loucaides, E; FITCHETT, E; GIRARDI, F; Horton, SE; Bray, F; Steliarova-Foucher, E; Sullivan, R; Aitken, JF; Banavali, S; Binagwaho, A; Alcasabas, P; Antillon, F; Arora, RS; ... Rodriguez-Galindo, C.

2020

The Lancet Oncology

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

ALLEMANI, C; Matsuda, T; DI CARLO, V; HAREWOOD, R; MATZ, M; NIKŠIĆ, M; BONAVENTURE, A; Valkov, M; Johnson, CJ; Estève, J; Ogunbiyi, OJ; Azevedo E Silva, G; Chen, W-Q; Eser, S; Engholm, G; Stiller, CA; Monnereau, A; Woods, RR; Visser, O; Lim, GH; Aitken, J; Weir, HK; COLEMAN, MP; CONCORD Working Group,;

2018

Lancet

Progress towards the WHO Global Initiative for Childhood Cancer target of 60% 5-year survival for all childhood cancers combined, 1990-2019 (CONCORD-4): a Cancer Survival Index derived for 68 countries by analysis of individual records for 613 021 children from 307 population-based cancer registries.

ALLEMANI, C; Di Carlo, V; Ssenyonga, N; Baloch, FK; Kuehni, C; GIRARDI, F; Goić, C; Sophiea, MK; Šekerija, M; Espinoza-Vallejos, C; Dadouli, K; Sugiyama, H; Galceran, J; Cañete-Nieto, A; Ragusa, R; Moreno, F; Stiller, C; COLEMAN, MP; CONCORD Working Group,;

2026

Lancet (London, England)

Trends in net survival for patients with brain tumors in Japan, 2000-14 (CONCORD-3).

Gatellier, L; Matz, M; Sugiyama, H; Oki, I; Shibata, A; Nakata, K; Saito, MK; Matsuzaka, M; Oze, I; Watanabe, K; Tanaka, R; Nishio, M; Yoshida, I; Ito, H; Teramoto, N; Yamashita, N; Kaizaki, Y; Moki, F; Kurosawa, K; Nemoto, Y; Narimatsu, H; Kanemura, S; Miyashiro, I; Mori, D; Fujita, S; ... DI CARLO, V.

2026